Cardiovascular Systems To Webcast Fiscal 2016 First-Quarter Earnings Conference Call Wednesday, November 4

Live Webcast at 3:45 p.m. CT (4:45 p.m. ET)

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2016 first-quarter conference call on Wednesday, November 4, 2015, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal first quarter ended September 30, 2015, and its financial outlook. The company will issue a post-market earnings release prior to the call on November 4.

To access the live webcast, go to the investor section of the company’s website, www.csi360.com, on the day of the conference call and click on the webcast icon. A webcast replay will be available beginning at 6:45 p.m. CT the same day.

To participate in the conference call, dial (877) 201-0168 and enter 65027583. Please dial in at least 10 minutes prior to the call.

If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial (855) 859-2056 and enter 65027583. The audio replay will be available beginning at 6:45 p.m. CT on Wednesday, November 4, 2015, through 10:59 p.m. CT on Wednesday, November 11, 2015.

About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. To date, over 220,000 of CSI’s devices have been sold to leading institutions across the United States. For more information, visit the company’s website at www.csi360.com.